Global Recombinant DNA Technology Market report examines the market position and viewpoint of the market globally, from various angles, such as key players, geological regions, types of product and application. And also cover the other information such as Recombinant DNA Technology Market trends, Top players, chapter-wise Description followed by various user perceptions and Forecast till 2023.
Global Recombinant DNA Technology Market – Overview
The recombinant DNA technology is a process that manipulates and alters the DNA sequences, resulting in a genetically modified organism and product. These genetically modified products or organisms have superior or specific ability such as resistance to certain chemicals, high productivity, and survival abilities in harsh conditions (GM crops).
The recombinant DNA technology has a practical application of biotechnology in the fields of applied immunology, genomics, diagnostic tools, and development of pharmaceutical therapeutics. There are numerous biological methods used to create a recombinant DNA. The treatment was developed for leukemia disorder, in conjugation between the Novartis Corp and the University of Pennsylvania.
Factors such as the commercial success of the recombinant DNA technology in the biopharmaceutical industry, the increasing adoption of genetically modified crops and biopesticides, and the increasing burden of chronic diseases are driving the growth of the market. Moreover, the increasing need to improve the recombinant protein production capacity and the presence of robust biopharmaceuticals pipeline are increasing the demand for effective therapeutics for disease treatment.
Presently, the genetic testing market is majorly spread in Western Europe and North American. There are vast opportunities for the companies and service providers to make the tests affordable and enter the untapped regions of the world with a great scope of expanding.
The global recombinant DNA technology market is expected to grow at a CAGR of approximately 6.9% during the forecast period, 2017–2023.
Get Exclusive Sample Copy of Recombinant DNA Technology Market @ https://www.marketresearchfuture.com/sample_request/5845
Recombinant DNA Technology Market – Leading players
Hoffmann-La Roche Ltd (Switzerland), Profacgen (U.S.), Amgen Inc. (U.S.), Novartis AG (Switzerland), Genscript Biotech (U.S.), Pfizer Inc. (U.S.), Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Sanofi S.A. (France), Merck & Co., Inc. (U.S.), Biogen Inc. (U.S.), Biocon Limited (India), GlaxoSmithKline plc (UK), New England Biolabs (U.S.), Cibus (U.S.), Monsanto Company (U.S.), Horizon Discovery Group PLC (U.S.), Boehringer Ingelheim (Germany), and others.
Global Recombinant DNA Technology Market – Regional Analysis
The global recombinant DNA technology market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas contributes a major share to the recombinant DNA technology market owing to the widespread successful applications of this technique in veterinary products’ development, genetically modified crops’ development, biopesticides’ and biofuels’ production, and gene therapy. All these factors are expected to spur the adoption of this technology throughout the forecast period.
The European market holds the second largest share of the global recombinant DNA technology market owing to the increasing investments by hospital facilities and by the government for better healthcare. The growing collaborations and partnerships, the low cost of sequencing, and the increasing adoption of NGS procedure by research laboratories are driving the growth of this market.
The Asia Pacific region is expected to witness a rapid growth rate over the forecast period. Countries such as India and China are expected to support the growth of Asia Pacific owing to the increasing government funding for research and development. Moreover, conducting clinical trials in Asian countries such as India are relatively less costly in comparison with the western countries. This has resulted in the migration of several global biopharmaceutical developers towards this region.
The Middle East and Africa are also expected to show healthy growth in the coming five years. There are some factors affecting the growth of the recombinant DNA technology in the Middle East such as lack of knowledge of genetic diseases and disorders, weak health care and research infrastructure, traditional healthcare practices, limited availability of products and services, and cost of the tests.
Global Recombinant DNA Technology – Market Segmentation
The global recombinant DNA technology market is segmented on the basis of product, component, application, and end-user. On the basis of product, the global recombinant DNA technology market is segmented into medical, non-medical, and others. The medical segment is divided into therapeutic agents, human proteins, and vaccines. The non-medical segment is divided into biotech crops, specialty chemicals, and others.
On the basis of component, the global recombinant DNA technology market is segmented into expression system, cloning vector, and others. The expression system segment is divided into mammalian, bacteria, yeast, baculovirus/insect, and others. The cloning vector segment is divided into plasmid, phage, cosmid, Bacterial Artificial Chromosome (BAC), Yeast Artificial Chromosome (YAC), and Human Artificial Chromosome (HAC).
On the basis of application, the global recombinant DNA technology market is segmented into food and agriculture, health and disease, environment, and others. On the basis of end-user, the global recombinant DNA technology market is segmented into biotechnology companies, academic and government research institutes, pharmaceuticals, and others.
Get Amazing Discount on Report @ https://www.marketresearchfuture.com/check-discount/5845
TOC of Recombinant DNA Technology Market Research Report – Global Forecast to 2023
- Report Prologue
- Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
- Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
- Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Threats
4.5 Macroeconomic Indicators
TOC CONTINUED…
Ask any Queries to Experts about Niche Segments, Requires Regional Data and Top Players @ https://www.marketresearchfuture.com/enquiry/5845
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Your information will never be shared with any third party.